e-learning
resources
Milan 2017
Sunday, 10.09.2017
Novel mechanisms and treatments for asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Fevipiprant reduces airway smooth muscle mass in asthmatics via PGD2 receptor antagonism
R. Saunders (Leicester, United Kingdom)
Source:
International Congress 2017 – Novel mechanisms and treatments for asthma
Session:
Novel mechanisms and treatments for asthma
Session type:
Oral Presentation
Number:
283
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Saunders (Leicester, United Kingdom). Fevipiprant reduces airway smooth muscle mass in asthmatics via PGD2 receptor antagonism. 283
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
The PPARgamma agonist ciglitizone inhibits CXCL10 release by asthmatic and non-asthmatic airway smooth muscle cells
Source: Eur Respir J 2006; 28: Suppl. 50, 339s
Year: 2006
Prostacyclin IP receptor activation blocks hyperosmolar-induced bronchoconstriction in isolated human small airways
Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action
Year: 2016
Potentiation effect of insulin on M3 muscarinic receptor agonist induced airway smooth muscle contraction
Source: International Congress 2019 – Airway inflammation: pharmacological mechanisms and novel targets
Year: 2019
Involvement of the BK channels/G proteins processes in the synergistic effects between anticholinergic agents and beta
2
-adrenoceptor agonists in airway smooth muscle
Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management
Year: 2013
The effect of adenosine on VEGF release from airway smooth muscle from subjects with asthma
Source: Annual Congress 2013 –Airway smooth muscle and cell biology
Year: 2013
Central role of AC6 in β2 agonist induced relaxation of human airway smooth muscle
Source: International Congress 2016 – Novel insights into the treatment of COPD
Year: 2016
Increased relaxation of immature airways to beta-2 agonists is related to the attenuated expression of postjunctional smooth muscle muscarinic M2 receptors
Source: Annual Congress 2004 - Understanding the complexity of how airways are regulated
Year: 2004
Insulin acutely potentiates M3 muscarinic receptor function in rat and human airway smooth muscle
Source: International Congress 2017 – Therapeutic approaches in lung disease
Year: 2017
A comparison of beta
2
-adrenoceptor desensitisation induced by olodaterol and formoterol in human lung mast cells and airway smooth muscle cells
Source: Annual Congress 2013 –New drugs in respiratory medicine
Year: 2013
Delayed and persistent suppression of bronchoconstriction by trypsin in the airway lumen
Source: Eur Respir J 2006; 27: 20-28
Year: 2006
Estrogen requires the NO-cGMP-PKG pathway in order to prevent the hyper-responsiveness of asthmatic tracheal smooth muscle to carbachol
Source: Annual Congress 2005 - Highlights of the 2005 ERS Lung Science Conference in Taormina
Year: 2005
Role of airway smooth muscles in chronic airway inflammation and lung fibrosis and possible therapeutic potential of endothelin receptor antagonism
Source: Annual Congress 2010 - New mechanisms in lung development, acute and chronic lung diseases
Year: 2010
Beta2-agonists but not glucocorticoids inhibit proliferation of asthmatic airway smooth muscle cells
Source: Eur Respir J 2004; 24: Suppl. 48, 251s
Year: 2004
Endothelin receptor B protects GM-CSF mRNA from degradation in human airway smooth muscle cells
Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects
Year: 2015
Impaired inhibitory action of corticosteroids on chemokine expression induced by TNFalpha in airway smooth muscle (ASM) cells from patients with severe asthma
Source: Annual Congress 2013 –Airway smooth muscle and cell biology
Year: 2013
Muscarinic M3 receptor stimulation increases cigarette smoke-induced IL-8 secretion by human airway smooth muscle cells
Source: Eur Respir J 2009; 34: 1436-1443
Year: 2009
Collagen remodelling by airway smooth muscle is resistant to steroids and beta 2-agonists
Source: Eur Respir J 2011; 37: 173-182
Year: 2011
Mechanisms of bronchial hyperresponsiveness in a clinical setting – putative role of smooth muscle
Source: Annual Congress 2005 - Role of the bronchial smooth muscle in regulating airway disease
Year: 2005
Airway hyperresponsiveness development is related to airway smooth muscle cytosolic β1 integrin subunit expressing cells
Source: Annual Congress 2010 - Airway smooth muscle cells
Year: 2010
Cysteinyl leukotrienes augment human airway smooth muscle migration
Source: Eur Respir J 2002; 20: Suppl. 38, 384s
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept